Aquestive Therapeutics Inc (AQST)
2.90
-0.01
(-0.34%)
USD |
NASDAQ |
May 31, 16:00
2.895
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics Accounts Receivable (Quarterly): 6.703M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.703M |
December 31, 2023 | 5.57M |
September 30, 2023 | 6.846M |
June 30, 2023 | 7.969M |
March 31, 2023 | 4.122M |
December 31, 2022 | 3.274M |
September 30, 2022 | 9.358M |
June 30, 2022 | 16.24M |
March 31, 2022 | 18.62M |
December 31, 2021 | 9.678M |
September 30, 2021 | 11.50M |
June 30, 2021 | 9.626M |
March 31, 2021 | 8.128M |
Date | Value |
---|---|
December 31, 2020 | 4.33M |
September 30, 2020 | 6.659M |
June 30, 2020 | 11.81M |
March 31, 2020 | 8.47M |
December 31, 2019 | 9.094M |
September 30, 2019 | 9.687M |
June 30, 2019 | 10.04M |
March 31, 2019 | 7.327M |
December 31, 2018 | 6.552M |
September 30, 2018 | 7.431M |
June 30, 2018 | 6.576M |
March 31, 2018 | 9.292M |
December 31, 2017 | 6.101M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
3.274M
Minimum
Dec 2022
18.62M
Maximum
Mar 2022
8.886M
Average
8.782M
Median
Accounts Receivable (Quarterly) Benchmarks
Lifecore Biomedical Inc | 29.71M |
Harrow Inc | 28.96M |
Akebia Therapeutics Inc | 26.62M |
89bio Inc | -- |
Humacyte Inc | -- |